People: Stryker Corp (SYK.N)
Dr. Roch Doliveux, DVM, is Independent Director of Stryker Corp., since June 21, 2010. He is a Former Chief Executive Officer and Chairman of the Executive Committee of UCB S.A., a global biopharmaceutical company, from 2005 through 2014. Prior thereto, he was Chief Executive Officer of Pierre Fabre Pharmaceuticals and President of Schering-Plough International, a subsidiary of Schering-Plough Corporation, now Merck and Co. He is Chairman of the GLG Healthcare Institute, a community of senior executives for experience sharing and learning and Vice Chairman of the Board of the Vlerick Business School, a top-100 business school in the world based in Belgium.
|Total Annual Compensation, USD||118,152|
|Restricted Stock Awards, USD||88,380|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||80,982|
|Fiscal Year Total, USD||287,514|